Johnson & Johnson

Stock Chart, Company Information, and Scan Results

$269.12(as of Sep 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Johnson & Johnson Company Information, Fundamentals, and Technical Indicators

Stock Price$269.12
Ticker SymbolJNJ
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees138,200
CountyUSA
Market Cap$663,276.4M
EBIDTA34,872.0M
10-Day Moving Average271.20
P/E Ratio31.22
20-Day Moving Average267.98
Forward P/E Ratio21.74
50-Day Moving Average261.04
Earnings per Share8.61
200-Day Moving Average233.85
Profit Margin21.86%
RSI53.35
Shares Outstanding2,409.9M
ATR5.71
52-Week High281.07
Volume7,764,172
52-Week Low169.49
Most Recent Support Level273.16
Book Value84,970.0M
Most Recent Resistance Level281.07
P/B Ratio7.73
Upper Keltner280.83
P/S Ratio6.71
Lower Keltner255.13
Debt-to-Equity Ratio0.58
Next Earnings Date10/13/2026
Cash Surplus-34,473.0M
Next Ex-Dividend DateUnknown

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.